Regulatory PathRegulatory requirements compared

Active substance

Pizotifen

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
APPI- D 0.5MG-10ML SYRUP50 µ/mlSyrup · Oral use1 BottleSAR 18.00Generic · PrescriptionDEEF PHARMACEUTICAL INDUSTRIESValid
MOSEGOR 0.5MG SUGAR COATED TABLETS0.5 mgCoated tablet · Oral use30 BlisterSAR 17.70NCE · OTCETHYX PHARMACEUTICALSValid
MOSEGOR SYRUP50 µ/mlSyrup · Oral use1 BottleSAR 20.05NCE · PrescriptionETHYX PHARMACEUTICALSValid
ZOFEN SYRUP 0.5MG-10ML50 µ/mlSyrup · Oral use1 BottleSAR 12.65Generic · PrescriptionJazeera Pharmaceutical Industries (JPI)Withdrawn by MAH · Not Marketed

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
SANDOMIGRAN DS005115521 MGTABLET · ORALKNIGHT THERAPEUTICS INC.

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
NHS Drug TariffPizotifen 1.5mg tablets£1.6428 tablet1 Oct 2026
NHS Drug TariffPizotifen 500microgram tablets£1.0928 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.